EcoDrugPlus

Trace Amine-Associated Receptor 13c-Like

Ensembl ID : ENSSPAG00000007508
Gene Symbol: LOC103365608
2 Cross references
121 Possible Orthologues:

Transforming Growth Factor Beta Receptor 1

Ensembl ID : ENSSPAG00000020475
Gene Symbol: TGFBR1
3 Cross references
204 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1-Like

Ensembl ID : ENSSPAG00000015000
Gene Symbol: LOC103370345
3 Cross references
200 Possible Orthologues:

Transthyretin

Ensembl ID : ENSSPAG00000011796
Gene Symbol: TTR
3 Cross references
178 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSSPAG00000022527
Gene Symbol: TPH1
3 Cross references
207 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSSPAG00000005459
Gene Symbol: TUBA4A
3 Cross references
170 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSSPAG00000004732
Gene Symbol: TUBA4A
4 Cross references
156 Possible Orthologues:

Tubulin Alpha-1b Chain

Ensembl ID : ENSSPAG00000018630
Gene Symbol: LOC103365678
3 Cross references
188 Possible Orthologues:

Tubulin Beta Chain-Like

Ensembl ID : ENSSPAG00000015214
Gene Symbol: LOC103355893
2 Cross references
184 Possible Orthologues:

Tubulin Beta Class I

Ensembl ID : ENSSPAG00000017353
Gene Symbol: TUBB
3 Cross references
183 Possible Orthologues:

Tubulin Beta-2a Chain-Like

Ensembl ID : ENSSPAG00000006137
Gene Symbol: LOC103371147
3 Cross references
305 Possible Orthologues:

Tubulin Beta-4b Chain-Like

Ensembl ID : ENSSPAG00000000518
Gene Symbol: LOC103372308
2 Cross references
21 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).